Brief: Galmed Announces Meaningful Top Line Results From Am-001 Study Of Aramchol Meglumine
18/11/2025 13:38
Galmed Pharmaceuticals Ltd GLMD.O: GALMED ANNOUNCES MEANINGFUL TOP LINE RESULTS FROM AM-001 STUDY OF ARAMCHOL MEGLUMINE GALMED PHARMACEUTICALS- TOP-LINE RESULTS SHOWED THAT BIOAVAILABILITY OF ARAMCHOL MEGLUMINE 400MG AND 200MG GRANULES IS CONSIDERABLY GREATER Source text: ID:nPn2HrpcGa Further company coverage: GLMD.O